Malathion detoxification by human hepatic carboxylesterases and its inhibition by isomalathion and other pesticides

被引:29
作者
Buratti, FM [1 ]
Testai, E [1 ]
机构
[1] Ist Super Sanita, Environm & Primary Prevent Dept, I-00161 Rome, Italy
关键词
malathion; organophosphorothionate pesticides; human liver carboxylesterases; detoxification; inhibition; interactions;
D O I
10.1002/jbt.20106
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The organophosphorothioate (OPT) pesticide malathion (MAL) in mammals is readily hydrolyzed by mammalian carboxylesterases (CE). The reaction competes with the CYP-catalyzed formation of malaoxon (MOX), the toxic metabolite. Alterations or individual variations in CE activity may result in increased MOX formation, enhancing MAL toxicity. We have characterized the human hepatic CE activity in a panel of 18 human liver microsomes as well as the inhibitory effect of IsoMAL, a major impurity of MAL commercial formulations, parathion (PAR), chlorpyrifos (CPF), and chlorpyrifos-oxon (CPFO). CE activity showed a low level of variation among individuals (4-fold). The reaction consists of two different phases, differing in their affinity for MAL (K-m1 = 0.25-0.69 mu M; K-m2 = 10.3-26.8 mu M). The relatively low K-m1 values confirmed that human CE efficiently detoxify MAL. IsoMAL was shown to be a potent noncompetitive inhibitor of MAL detoxification (K-i = 0.6 mu M), with a higher inhibitory potency than CPF and PAR (K-i = 7.5 mu M and 50 mu M, respectively). These two latter compounds very likely act as mixed inhibitors. CPFO showed the highest inhibitory potency toward CE-mediated detoxification, being characterized by a K-i = 22 nM. The present results provide useful information for a better understanding of possible interactions between different OPTs and for assessing the potential cumulative risk for exposure to OPT mixtures. (c) 2005 Wiley Periodicals, Inc.
引用
收藏
页码:406 / 414
页数:9
相关论文
共 32 条
  • [1] Measurement of children's exposure to pesticides: Analysis of urinary metabolite levels in a probability-based sample
    Adgate, JL
    Barr, DB
    Clayton, CA
    Eberly, LE
    Freeman, NCG
    Lioy, PJ
    Needham, LL
    Pellizzari, ED
    Quackenboss, JJ
    Roy, A
    Sexton, K
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 2001, 109 (06) : 583 - 590
  • [2] ALDRIDGE WN, 1979, ARCH TOXICOL, V42, P95
  • [3] BAKER EL, 1978, LANCET, V1, P31
  • [4] STUDIES ON FACTORS INFLUENCING ACUTE TOXICITY OF MALATHION AND MALAOXON IN RATS
    BRODEUR, J
    DUBOIS, KP
    [J]. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1967, 45 (04) : 621 - &
  • [5] Malathion bioactivation in the human liver: The contribution of different cytochrome P450 isoforms
    Buratti, FM
    D'Aniello, A
    Volpe, MT
    Meneguz, A
    Testai, E
    [J]. DRUG METABOLISM AND DISPOSITION, 2005, 33 (03) : 295 - 302
  • [6] CYP-specific bioactivation of four organophosphorothioate pesticides by human liver microsomes
    Buratti, FM
    Volpe, MT
    Meneguz, A
    Vittozzi, L
    Testai, E
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 2003, 186 (03) : 143 - 154
  • [7] NONCATALYTIC DETOXICATION OF 6 ORGANOPHOSPHORUS COMPOUNDS BY RAT-LIVER HOMOGENATES
    CHAMBERS, H
    BROWN, B
    CHAMBERS, JE
    [J]. PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY, 1990, 36 (03) : 308 - 315
  • [8] DAUTERMAN WC, 1971, B WORLD HEALTH ORGAN, V44, P133
  • [9] Organophosphorothionate pesticides inhibit the bioactivation of imipramine by human hepatic cytochrome P450s
    Di Consiglio, E
    Meneguz, A
    Testai, E
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 2005, 205 (03) : 237 - 246
  • [10] CHARACTERIZATION OF MOLECULAR-SPECIES OF LIVER MICROSOMAL CARBOXYLESTERASES OF SEVERAL ANIMAL SPECIES AND HUMANS
    HOSOKAWA, M
    MAKI, T
    SATOH, T
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1990, 277 (02) : 219 - 227